S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Immunovant (IMVT) SEC Filings & 10K Form

$35.99
-0.51 (-1.40%)
(As of 02/22/2024 ET)

Recent Immunovant SEC Filings

DateFilerForm TypeView
02/14/2024
7:47 AM
Deep Track Capital, LP (Filed by)
Immunovant (Subject)
Form SC 13G/A
02/12/2024
6:02 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:05 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/09/2024
8:16 AM
Immunovant (Subject)
Form SC 13G
01/19/2024
3:04 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:29 AM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/12/2024
3:34 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:18 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:20 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:08 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:37 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
3:25 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:28 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:30 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:19 PM
Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:19 PM
Fromkin Andrew J. (Reporting)
Immunovant (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:20 PM
Immunovant (Subject)
Pande Atul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
6:43 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
1:55 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:45 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:47 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:51 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:41 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
7:49 AM
Immunovant (Filer)
Form S-3ASR
11/09/2023
6:06 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:13 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/20/2023
3:06 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:11 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:10 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:15 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:15 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:19 PM
Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
09/29/2023
3:48 PM
Immunovant (Filer)
Form 424B5
09/28/2023
4:23 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
5:09 AM
Immunovant (Subject)
Form FWP
09/26/2023
7:00 PM
Immunovant (Subject)
Form FWP
09/26/2023
4:28 PM
Immunovant (Filer)
Form 424B5
09/26/2023
6:45 AM
Immunovant (Filer)
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
4:00 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
4:03 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
4:05 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:57 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:48 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
3:11 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
6:19 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:10 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
3:35 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:37 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
4:10 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
4:11 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
6:35 AM
Immunovant (Filer)
Form DEFA14A
06/26/2023
6:26 AM
Immunovant (Filer)
Form DEF 14A
05/22/2023
6:03 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:10 AM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/19/2023
3:15 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2023
3:19 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2023
3:23 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:31 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:33 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:35 PM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:37 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:19 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:22 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:24 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:26 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:29 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2023
6:07 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IMVT) was last updated on 2/23/2024 by MarketBeat.com Staff